Role of matrix metalloproteinases in delayed cortical responses after stroke

Nature Medicine

Volumn 12, Issue 4, 2006, Pages 441-445

  Zhao, Bing Qiao ^a,b   Wang, Sophia ^a,b   Kim, Hahn Young ^a,b,d   Storrie, Hannah ^c   Rosen, Bruce R ^a   Mooney, David J ^c   Wang, Xiaoying ^a,b   Lo, Eng H ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD UNIVERSITY   (United States)

^d Konkuk University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; BRAIN CORTEX; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; ENZYME INHIBITION; FUNCTIONAL DISEASE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SIGNAL TRANSDUCTION; STROKE; UPREGULATION;

ANIMALS; BIOLOGICAL MARKERS; BRAIN INFARCTION; BRAIN ISCHEMIA; CEREBRAL CORTEX; CEREBROVASCULAR ACCIDENT; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 9; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASES; UP-REGULATION;

ANIMALIA;

EID: 33645744014     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1387     Document Type: Article

References (30)

1. Yong, V.W. Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat. Rev. Neurosci. 6, 931-944 (2005).
2. Asahi, M. et al. Effects of matrix metalloproteinase 9 gene knockout on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci. 21, 7724-7732 (2001).
3. Wang, X. et al. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Nat. Med. 9, 1313-1317 (2003).
4. Lo, E.H., Dalkara, T. & Moskowitz, M.A. Mechanisms, challenges and opportunities in stroke. Nat. Rev. Neurosci. 4, 399-415 (2003).
5. Lee, S.R. & Lo, E.H. Induction of caspase-mediated cell death by matrix metalloproteinases in cerebral endothelial cells after hypoxia-reoxygenation. J. Cereb. Blood Flow Metab. 24, 720-727 (2004).
6. Gu, Z. et al. A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. J. Neurosci. 25, 6401-6408 (2005).
7. Gasche, Y. et al. Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction. J. Cereb. Blood Flow Metab. 19, 1020-1028 (1999).
8. Heo, J.H. et al. Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J. Cereb. Blood Flow Metab. 19, 624-633 (1999).
9. Mun-Bryce, S. & Rosenberg, G.A. Matrix metalloproteinases in cerebrovascular disease. J. Cereb. Blood Flow Metab. 18, 1163-1172 (1998).
10. Dijkhuizen, R.M. et al. Correlation between brain reorganization, ischemic damage, and neurologic status after transient focal cerebral ischemia in rats: a functional magnetic resonance imaging study. J. Neurosci. 23, 510-517 (2003).
11. Kim, Y.R. et al. Measurements of BOLD/CBV ratio show altered fMRI hemodynamics during stroke recovery in rats. J. Cereb. Blood Flow Metab. 25, 820-829 (2005).
12. Reeves, T.M., Prins, M.L., Zhu, J., Povlishock, J.T. & Phillips, L.L. Matrix metalloproteinase inhibition alters functional and structural correlates of deafferentation-induced sprouting in the dentate gyrus. J. Neurosci. 23, 10182-10189 (2003).
13. Wallace, C.S. et al. Correspondence between sites of NGFI-A induction and sites of morphological plasticity following exposure to environmental complexity. Brain Res. Mol. Brain Res. 32, 211-220 (1995).
14. Jones, M.W. et al. A requirement for the immediate early gene Zif268 in the expression of late LTP and long-term memories. Nat. Neurosci. 4, 289-296 (2001).
15. Irving, E.A. et al. Identification of neuroprotective properties of anti-MAG antibody: a novel approach for the treatment of stroke? J. Cereb. Blood Flow Metab. 25, 98-107 (2005).
16. Omura, K. et al. Recovery of blood-nerve barrier in crush nerve injury - a quantitative analysis utlizing immunohistochemistry. Brain Res. 1001, 13-21 (2004).
17. Larsen, PH., Wells, J.E., Stallcup, W.B., Opdenakker, G. & Yong, V.W. Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan. J. Neurosci. 23, 11127-11135 (2003).
18. Pang, P.T. et al. Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 306, 487-491 (2004).
19. Bergers, G. et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2, 737-744 (2000).
20. Zhang, Z.G. et al. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J. Clin. Invest. 106, 829-838 (2000).
21. Cramer, S.C. & Chopp, M. Recovery recapitulates ontogeny. Trends Neurosci. 23, 265-271 (2000).
22. Chmielnicki, E. & Goldman, S.A. Induced neurogenesis by endogenous progenitor cells in the adult mammalian brain. Prog. Brain Res. 138, 451-464 (2002).
23. Kaczmarek, L., Lapinska-Dzwonek, J. & Szymczak, S. Matrix metalloproteinases in the adult brain physiology: a link between c-Fos, AP-1 and remodeling of neuronal connections? EMBO J. 21, 6643-6648 (2002).
24. Pepper, M.S. Role of the matrix metalloproteinase and plasmminogen activator-plasmin systems in angiogenesis. Arterioscler. Thromb. Vasc. Biol. 21, 1104-1117 (2001).
25. Manoonkitiwongsa, P.S., Jackson-Friedman, C., Mcmillan, P.J., Schultz, R.L. & Lyden, P.D. Angiogenesis after stroke is correlated with increased numbers of macrophages: the clean-up hypothesis. J. Cereb. Blood Flow Metab. 21, 1223-1231 (2001).
26. Silva, E.A. & Mooney, D.J. Synthetic extracellular matrices for tissue engineering and regeneration. Curr. Top. Dev. Biol. 64, 181-205 (2004).
27. Montaner, J. et al. Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment. Stroke 32, 1759-1766 (2001).
28. Montaner, J. et al. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation 107, 598-603 (2003).
29. Lee, S.R., Tsuji, K., Lee, S.R. & Lo, E.H. Role of matrix metalloproteinases in delayed neuronal damage after transient global cerebral ischemia. J. Neurosci. 24, 671-678 (2004).
30. Taguchi, A. et al. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J. Clin. Invest. 114, 330-338 (2004).